Search Results - "Lother, S."

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry by Mathur, S., Christou, G., Delage, R., Elemary, M., Finn, N., Geddes, M., Houston, DS, Keating, MM, Khalaf, D., Leber, B., Leitch, H., Lother, SA, Mozessohn, L., Nevill, T., Parmentier, A., Paulson, K., Rimmer, E., Sabloff, M., Shamy, A., St-Hilaire, E., Storring, J., Yee, K., Zhang, L., Zhu, N., Hay, AE, Zarychanski, R., Buckstein, R., Houston, Brett L.

“…Infections are a significant cause of morbidity and mortality in myelodysplastic syndrome (MDS). Precise estimates of infection frequency and severity with…”
Get full text

Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada by Lother, S. A., Harding, G. A., Musto, G., Navaratnam, S., Pitz, M. W.

“…Lung cancer is the leading cause of cancer death worldwide. Sex differences in lung cancer incidence and survival are known. Female sex is an independent good…”
Get full text

Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY by Mathur, S., Christou, G., Delage, R., Elemary, M., Finn, N., Geddes, M., Houston, D., Keating, M.-M., Khalaf, D., Leber, B., Leitch, H., Lother, S., Mozessohn, L., Nevill, T., Parmentier, A., Paulson, K., Rimmer, E., Sabloff, M., Shamy, A., St-Hilaire, E., Storring, J., Yee, K., Zhang, L., Zhu, N., Hay, A., Zarychanski, R., Buckstein, R., Houston, B.

Get full text

OC 05.2 Impact of Heparin on Disease State Transition in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT by Tays, Q., Houston, B., Teng, W., Balshaw, R., Lawler, P., Lother, S., Garland, A., Mendelson, A., Rimmer, E., Houston, D., Neal, M., Farkouh, M., Carrier, M., Goligher, E., Castellucci, L., Ariano, R., Falk, J., Heath, A., Zarychanski, R.

Get full text

OC 29.4 Impact of Symptom Duration on Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT by Tays, Q., Teng, W., Houston, B., Balshaw, R., Lawler, P., Lother, S., Garland, A., Mendelson, A., Rimmer, E., Houston, D., Neal, M., Farkouh, M., Carrier, M., Goligher, E., Castellucci, L., Falk, J., Ariano, R., Heath, A., Zarychanski, R.

Get full text

PB0052 Heparin Type & Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19: Secondary Analysis of an International Multi-Platform RCT by Tays, Q., Houston, B., Teng, W., Balshaw, R., Lawler, P., Lother, S., Garland, A., Mendelson, A., Rimmer, E., Houston, D., Neal, M., Farkouh, M., Carrier, M., Goligher, E., Castellucci, L., Ariano, R., Falk, J., Heath, A., Zarychanski, R.

Get full text